Cargando…

Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK

BACKGROUND: Haemophilus influenzae is commonly isolated from the airways of COPD patients. Antibiotic treatment may cause the emergence of resistant H. influenzae strains, particularly ampicillin-resistant strains, including β-lactamase-negative ampicillin resistance (BLNAR) strains. Genetic identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddi, Satyanarayana, Kolsum, Umme, Jackson, Sarah, Barraclough, Richard, Maschera, Barbara, Simpson, Karen D, Pascal, Thierry G, Durviaux, Serge, Hessel, Edith M, Singh, Dave
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446963/
https://www.ncbi.nlm.nih.gov/pubmed/28579769
http://dx.doi.org/10.2147/COPD.S135338
_version_ 1783239199793610752
author Maddi, Satyanarayana
Kolsum, Umme
Jackson, Sarah
Barraclough, Richard
Maschera, Barbara
Simpson, Karen D
Pascal, Thierry G
Durviaux, Serge
Hessel, Edith M
Singh, Dave
author_facet Maddi, Satyanarayana
Kolsum, Umme
Jackson, Sarah
Barraclough, Richard
Maschera, Barbara
Simpson, Karen D
Pascal, Thierry G
Durviaux, Serge
Hessel, Edith M
Singh, Dave
author_sort Maddi, Satyanarayana
collection PubMed
description BACKGROUND: Haemophilus influenzae is commonly isolated from the airways of COPD patients. Antibiotic treatment may cause the emergence of resistant H. influenzae strains, particularly ampicillin-resistant strains, including β-lactamase-negative ampicillin resistance (BLNAR) strains. Genetic identification using ftsI sequencing is the optimum method for identifying mutations within BLNAR strains. The prevalence of BLNAR in COPD patients during the stable state has not been reported. We investigated the antibiotic resistance patterns of H. influenzae present in the sputum of stable COPD patients, focusing on ampicillin resistance; the prevalence of enzyme and non-enzyme-mediated ampicillin resistance was determined. A subset of patients was followed up longitudinally to study H. influenzae strain switching and antibiotic sensitivity changes. PATIENTS AND METHODS: Sputum sampling was performed in 61 COPD patients, with 42 samples obtained at baseline; H. influenzae was detected by polymerase chain reaction in 28 samples. In all, 45 patients completed the follow-up for 2 years; 24 H. influenzae isolates were obtained. RESULTS: Disk diffusion showed the highest antibiotic resistance in the penicillin antibiotic group (eg, 67% for ampicillin) and macrolides (eg, 46% for erythromycin), whereas all isolates were susceptible to quinolones. Of the 16 isolates resistant to ampicillin, 9 (56%) were β-lactamase positive. The β-lactamase-negative isolates were further investigated; none of these fulfilled the phenotypic BLNAR classification criteria of ampicillin minimum inhibitory concentration >1 µg/mL, and only one demonstrated an ftsI mutation. Frequent H. influenzae strain switching was confirmed using multilocus sequence typing and was associated with changes in the antibiotic sensitivity pattern. CONCLUSION: We observed an overidentification of ampicillin resistance by disk diffusion. The majority of ampicillin resistance was due to enzyme production. H. influenzae strain changes during the stable state may be associated with a change in antibiotic sensitivity; this has implications for empirical antibiotic prescribing.
format Online
Article
Text
id pubmed-5446963
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54469632017-06-02 Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK Maddi, Satyanarayana Kolsum, Umme Jackson, Sarah Barraclough, Richard Maschera, Barbara Simpson, Karen D Pascal, Thierry G Durviaux, Serge Hessel, Edith M Singh, Dave Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Haemophilus influenzae is commonly isolated from the airways of COPD patients. Antibiotic treatment may cause the emergence of resistant H. influenzae strains, particularly ampicillin-resistant strains, including β-lactamase-negative ampicillin resistance (BLNAR) strains. Genetic identification using ftsI sequencing is the optimum method for identifying mutations within BLNAR strains. The prevalence of BLNAR in COPD patients during the stable state has not been reported. We investigated the antibiotic resistance patterns of H. influenzae present in the sputum of stable COPD patients, focusing on ampicillin resistance; the prevalence of enzyme and non-enzyme-mediated ampicillin resistance was determined. A subset of patients was followed up longitudinally to study H. influenzae strain switching and antibiotic sensitivity changes. PATIENTS AND METHODS: Sputum sampling was performed in 61 COPD patients, with 42 samples obtained at baseline; H. influenzae was detected by polymerase chain reaction in 28 samples. In all, 45 patients completed the follow-up for 2 years; 24 H. influenzae isolates were obtained. RESULTS: Disk diffusion showed the highest antibiotic resistance in the penicillin antibiotic group (eg, 67% for ampicillin) and macrolides (eg, 46% for erythromycin), whereas all isolates were susceptible to quinolones. Of the 16 isolates resistant to ampicillin, 9 (56%) were β-lactamase positive. The β-lactamase-negative isolates were further investigated; none of these fulfilled the phenotypic BLNAR classification criteria of ampicillin minimum inhibitory concentration >1 µg/mL, and only one demonstrated an ftsI mutation. Frequent H. influenzae strain switching was confirmed using multilocus sequence typing and was associated with changes in the antibiotic sensitivity pattern. CONCLUSION: We observed an overidentification of ampicillin resistance by disk diffusion. The majority of ampicillin resistance was due to enzyme production. H. influenzae strain changes during the stable state may be associated with a change in antibiotic sensitivity; this has implications for empirical antibiotic prescribing. Dove Medical Press 2017-05-22 /pmc/articles/PMC5446963/ /pubmed/28579769 http://dx.doi.org/10.2147/COPD.S135338 Text en © 2017 Maddi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Maddi, Satyanarayana
Kolsum, Umme
Jackson, Sarah
Barraclough, Richard
Maschera, Barbara
Simpson, Karen D
Pascal, Thierry G
Durviaux, Serge
Hessel, Edith M
Singh, Dave
Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title_full Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title_fullStr Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title_full_unstemmed Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title_short Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK
title_sort ampicillin resistance in haemophilus influenzae from copd patients in the uk
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446963/
https://www.ncbi.nlm.nih.gov/pubmed/28579769
http://dx.doi.org/10.2147/COPD.S135338
work_keys_str_mv AT maddisatyanarayana ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT kolsumumme ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT jacksonsarah ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT barracloughrichard ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT mascherabarbara ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT simpsonkarend ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT pascalthierryg ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT durviauxserge ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT hesseledithm ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk
AT singhdave ampicillinresistanceinhaemophilusinfluenzaefromcopdpatientsintheuk